NCT03904329

Brief Summary

Obesity paradox In patient with non valvular atrial fibrillation

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 5, 2019

Completed
1.5 years until next milestone

Study Start

First participant enrolled

October 1, 2020

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

August 4, 2022

Status Verified

February 1, 2022

Enrollment Period

2.8 years

First QC Date

March 25, 2019

Last Update Submit

August 3, 2022

Conditions

Obesity Paradox

Outcome Measures

Primary Outcomes (1)

  • Correlation between obesity and outcomes in non valvular atrial fibrillation

    To study effect of obesity in outcomes of non valvular atrial fibrillation regarding the effect of obesity in the outcome of anticoagulants

    Sixth months

Study Arms (1)

Obese Patients with non valvular AF

Obese Patients with non valvular AF using oral anti coagulants

Drug: Oral Anticoagulant

Interventions

Oral AnticoagulantDRUG

Oral tablets of anti coagulations either warfare or NOACs

Obese Patients with non valvular AF

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Obese patients with non valvular atrial fibrillation within one year from 1/6/2019 to 31/5/2020 among patients with non valvular in assuit university hospitals

You may qualify if:

  • patients presented with non valvular AF
  • patients on oral anticoagulant

You may not qualify if:

  • valvular AF
  • Mental illness
  • History of cerebrovascular stroke
  • history of bleeding tendency
  • history of Chronic renal failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kristen amir

Asyut, 23123, Egypt

RECRUITING

MeSH Terms

Interventions

Anticoagulants

Intervention Hierarchy (Ancestors)

Hematologic AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Central Study Contacts

Christen Henan, Ressident

CONTACT

01201558854Christenamir@yahoo.com

Mahmmoed Abd e El saAbour, Assissetant professor

CONTACT

01001202779M_abd_elsabour@yahoo.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 25, 2019

First Posted

April 5, 2019

Study Start

October 1, 2020

Primary Completion

August 1, 2023

Study Completion

October 1, 2023

Last Updated

August 4, 2022

Record last verified: 2022-02

Locations

EG(1)